The FDA has approved a generic equivalent to Meda’s Astepro, an azelastine nasal spray, 0.1876MG, manufactured by Apotex. Meda filed a patent infringement suit in January 2012 after Apotex submitted its ANDA. The two companies settled after a similar suit regarding Apotex’s generic version of Astelin in 2008.
View the FDA approval history.
